TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 3 February 1, 2012
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 3 February 1, 2012
(The next issue will be on February 17, 2012)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1XoLfaNpIeJfor-4O9iaF2p/
Abbate R, Cioni G, Ricci I, Miranda M, Gori AM (2012) Thrombosis and Acute coronary syndrome. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22281070
Andersen LM, Andreasen PA, Svendsen I, Keemink J, Ostergaard H, Persson E (2012) Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22275370
Ando K, Ishibashi T, Ohkawara H, Inoue N, Sugimoto K, Uekita H, . . . Takeishi Y (2011) Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP) in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated endothelial cells. J Atheroscler Thromb 18:762-773.
http://www.ncbi.nlm.nih.gov/pubmed/21628952
Angelillo-Scherrer A (2012) Leukocyte-derived microparticles in vascular homeostasis. Circ Res 110:356-369.
http://www.ncbi.nlm.nih.gov/pubmed/22267840
Arderiu G, Pena E, Aledo R, Juan-Babot O, Badimon L (2011) Tissue factor regulates microvessel formation and stabilization by induction of chemokine (C-C motif) ligand 2 expression. Arterioscler Thromb Vasc Biol 31:2607-2615.
http://www.ncbi.nlm.nih.gov/pubmed/21868706
Ataga KI, Brittain JE, Desai P, May R, Jones S, Delaney J, . . . Key NS (2012) Association of coagulation activation with clinical complications in sickle cell disease. PLoS One 7:e29786.
http://www.ncbi.nlm.nih.gov/pubmed/22253781
Badeanlou L, Furlan-Freguia C, Yang G, Ruf W, Samad F (2011) Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat Med 17:1490-1497.
http://www.ncbi.nlm.nih.gov/pubmed/22019885
Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H (2011) Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. J Blood Med 2:131-134.
http://www.ncbi.nlm.nih.gov/pubmed/22287872
Bastarache JA, Sebag SC, Grove BS, Ware LB (2011) Interferon-gamma and tumor necrosis factor-alpha act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res 37:509-517.
http://www.ncbi.nlm.nih.gov/pubmed/21913843
Bobbert P, Eisenreich A, Weithauser A, Schultheiss HP, Rauch U (2011) Leptin and resistin induce increased procoagulability in diabetes mellitus. Cytokine 56:332-337.
http://www.ncbi.nlm.nih.gov/pubmed/21733717
Bretz N, Noske A, Keller S, Erbe-Hofmann N, Schlange T, Salnikov AV, . . . Altevogt P (2012) CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion. Clin Exp Metastasis 29:27-38.
http://www.ncbi.nlm.nih.gov/pubmed/21984372
Brown CV, Sowery L, Curry E, Valadka AB, Glover CS, Grabarkewitz K, . . . Admire J (2012) Recombinant Factor VIIa to Correct Coagulopathy in Patients with Traumatic Brain Injury Presenting to Outlying Facilities Before Transfer to the Regional Trauma Center. Am Surg 78:57-60.
http://www.ncbi.nlm.nih.gov/pubmed/22273315
Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, . . . Valesini G (2012) Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol 167:429-437.
http://www.ncbi.nlm.nih.gov/pubmed/22288586
Donati MB, Lorenzet R (2012) Thrombosis and cancer: 40years of research. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22264938
Ettelaie C, Fountain D, Collier ME, Elkeeb AM, Xiao YP, Maraveyas A (2011) Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-kappaB. Biochim Biophys Acta 1812:1591-1600.
http://www.ncbi.nlm.nih.gov/pubmed/21946214
Fadzil F (2011) Recurrent intracranial haemorrhages in a patient with factor seven deficiency: a case report. Med J Malaysia 66:261-263.
http://www.ncbi.nlm.nih.gov/pubmed/22111455
Foley JH, Butenas S, Mann KG, Brummel-Ziedins KE (2012) Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation. Anal Biochem.
http://www.ncbi.nlm.nih.gov/pubmed/22266209
Forte GI, Vaccarino L, Palmeri M, Branzi A, Caldarera CM, Scola L, . . . Lio D (2011) Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. Biogerontology 12:485-490.
http://www.ncbi.nlm.nih.gov/pubmed/21918818
Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA (2012) Intraoperative use of recombinant activated factor VII during complex aortic surgery. J Thorac Cardiovasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/22285329
Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev 12:CD009052.
http://www.ncbi.nlm.nih.gov/pubmed/22161443
Hall CL, Zaman FS (2012) A Computational Analysis of an In Vitro Vessel Wall Injury Model. Ann Biomed Eng.
http://www.ncbi.nlm.nih.gov/pubmed/22290588
Han CS, Schatz F, Lockwood CJ (2011) Abruption-associated prematurity. Clin Perinatol 38:407-421.
http://www.ncbi.nlm.nih.gov/pubmed/21890016
Hemmeryckx B, Van Hove CE, Fransen P, Emmerechts J, Kauskot A, Bult H, . . . Hoylaerts MF (2011) Progression of the prothrombotic state in aging Bmal1-deficient mice. Arterioscler Thromb Vasc Biol 31:2552-2559.
http://www.ncbi.nlm.nih.gov/pubmed/21799179
Herrera RN, Diaz de Amaya EI, Perez Aguilar RC, Joo Turoni C, Maranon R, Berman SG, . . . Peral de Bruno M (2011) Inflammatory and prothrombotic activation with conserved endothelial function in patients with chronic, asymptomatic Chagas disease. Clin Appl Thromb Hemost 17:502-507.
http://www.ncbi.nlm.nih.gov/pubmed/20699256
Hot A, Lenief V, Miossec P (2012) Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis.
http://www.ncbi.nlm.nih.gov/pubmed/22258491
Jan JY, Lin SY, Lin CH, Lee CN, Fan SZ, Han YY (2011) Recombinant activated factor VII as a promising adjuvant therapy for postpartum hemorrhage in the practice of obstetric anesthesia: experience from a university hospital in Taiwan. J Obstet Gynaecol Res 37:901-907.
http://www.ncbi.nlm.nih.gov/pubmed/21736669
Ji M, Yi S, Yu D, Wang W (2011) [siRNA-mediated tissue factor knockdown in porcine neonatal islet cell clusters in vitro]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36:1141-1146.
http://www.ncbi.nlm.nih.gov/pubmed/22246358
Kassel KM, Owens AP, 3rd, Rockwell CE, Sullivan BP, Wang R, Tawfik O, . . . Luyendyk JP (2011) Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. Am J Pathol 179:2278-2289.
http://www.ncbi.nlm.nih.gov/pubmed/21907177
Kathuria A, Priya N, Chand K, Singh P, Gupta A, Jalal S, . . . Sharma SK (2011) Substrate specificity of acetoxy derivatives of coumarins and quinolones towards Calreticulin mediated transacetylation: Investigations on antiplatelet function. Bioorg Med Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22264757
Kopp CW, Gremmel T, Steiner S, Seidinger D, Minar E, Maurer G, Huber K (2011) Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction. Platelets 22:530-536.
http://www.ncbi.nlm.nih.gov/pubmed/21557685
Kotani Y, Shiota M, Umemoto M, Koike E, Tsuritani M, Hoshiai H (2011) Case of acquired hemophilia with factor VIII inhibitor in a mother and newborn. J Obstet Gynaecol Res 37:1102-1105.
http://www.ncbi.nlm.nih.gov/pubmed/21450023
Le Sache F, Le Bonniec B, Gaussem P, Dizier B, Tagzirt M, Godier A, . . . Samama CM (2012) Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit. Br J Anaesth.
http://www.ncbi.nlm.nih.gov/pubmed/22258204
Leighton BL, Wall MH, Lockhart EM, Phillips LE, Zatta AJ (2011) Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports. Anesthesiology 115:1201-1208.
http://www.ncbi.nlm.nih.gov/pubmed/21720243
Liang YJ, Ma XC, Li X (2010) [The role of p38 mitogen-activated protein kinase/nuclear factor-KappaB transduction pathway on coagulation disorders due to endothelial injury induced by sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22:528-532.
http://www.ncbi.nlm.nih.gov/pubmed/20854731
Lipworth W, Kerridge I, Little M, Day R (2012) Evidence and desperation in off-label prescribing: recombinant factor VIIa. BMJ 344:d7926.
http://www.ncbi.nlm.nih.gov/pubmed/22250217
Liu ML, Williams KJ (2012) Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes.
http://www.ncbi.nlm.nih.gov/pubmed/22248645
Mackman N, Davis GE (2011) Blood coagulation and blood vessel development: is tissue factor the missing link? Arterioscler Thromb Vasc Biol 31:2364-2366.
http://www.ncbi.nlm.nih.gov/pubmed/22011746
Marchetti M, Russo L, Balducci D, Falanga A (2011) All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells. Thromb Res 128:368-374.
http://www.ncbi.nlm.nih.gov/pubmed/21458031
Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol 106:749-760.
http://www.ncbi.nlm.nih.gov/pubmed/21611880
Medioni J, Guastalla JP, Drouet L (2012) Thrombosis and breast cancer: incidence, risk factors, physiopathology and treatment. Bull Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/22285357
Mitrophanov AY, Reifman J (2011) Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 128:381-390.
http://www.ncbi.nlm.nih.gov/pubmed/21641634
Mulder R, Ten Kate MK, Kluin-Nelemans HC, Mulder AB (2012) PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels. Thromb Haemost 107.
http://www.ncbi.nlm.nih.gov/pubmed/22273984
Nadir Y, Kenig Y, Drugan A, Shafat I, Brenner B (2011) An assay to evaluate heparanase procoagulant activity. Thromb Res 128:e3-8.
http://www.ncbi.nlm.nih.gov/pubmed/21481923
Naumnik B, Rydzewska-Rosolowska A, Mysliwiec M (2011) Different effects of enoxaparin, nadroparin, and dalteparin on plasma TFPI during hemodialysis: a prospective crossover randomized study. Clin Appl Thromb Hemost 17:480-486.
http://www.ncbi.nlm.nih.gov/pubmed/20682597
Ogawa Y, Nishida Y, Kyo T, Miki H, Yonemoto H, Bandou H, . . . Shirasaka T (2011) [Successful completion of left total hip arthroplasty by inhibitor neutralization therapy in a hemophilia B patient with high responding inhibitor]. Rinsho Ketsueki 52:713-717.
http://www.ncbi.nlm.nih.gov/pubmed/21897080
Oishi K, Koyanagi S, Ohkura N (2011) Circadian mRNA expression of coagulation and fibrinolytic factors is organ-dependently disrupted in aged mice. Exp Gerontol 46:994-999.
http://www.ncbi.nlm.nih.gov/pubmed/21963655
Pacheco LD, Saade GR, Gei AF, Hankins GD (2011) Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 205:526-532.
http://www.ncbi.nlm.nih.gov/pubmed/21816382
Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, . . . Panteleev MA (2011) Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 9:1825-1834.
http://www.ncbi.nlm.nih.gov/pubmed/21696535
Reimer J, Bien S, Ameling S, Hammer E, Volker U, Hempel G, . . . Ritter CA (2012) Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis. Eur J Clin Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/22286157
Reitter-Pfoertner S, Horvath B, Lechner K, Sunder-Plassmann R, Mannhalter C, Pabinger I (2012) Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challenge. Wien Klin Wochenschr.
http://www.ncbi.nlm.nih.gov/pubmed/22249861
Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, . . . Fremeaux-Bacchi V (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain-of-function. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22246034
Sheth S, Soff G, Mitchell B, Green D, Kaicker S, Fireman F, . . . Aledort L (2012) Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus report. Expert Rev Hematol 5:47-50.
http://www.ncbi.nlm.nih.gov/pubmed/22272705
Stephan F, Aarden LA, Zeerleder S (2012) FSAP, a new player in inflammation? Hamostaseologie 32:51-55.
http://www.ncbi.nlm.nih.gov/pubmed/22252569
Taniguchi M, Ono N, Hayashi A, Yakura Y, Takeya H (2011) Effect of dibutyryl cyclic adenosine monophosphate on the gene expression of plasminogen activator inhibitor-1 and tissue factor in adipocytes. Thromb Res 128:375-380.
http://www.ncbi.nlm.nih.gov/pubmed/21496886
Tetik S, Ak K, Sahin Y, Gulsoy O, Isbir S, Arsan S, Yardimci T (2011) Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. Clin Appl Thromb Hemost 17:526-531.
http://www.ncbi.nlm.nih.gov/pubmed/20805103
Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24-28.
http://www.ncbi.nlm.nih.gov/pubmed/21624643
van der Poll T, Levi M (2012) Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis. Curr Vasc Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/22272914
Walsh M, Thomas SG, Howard JC, Evans E, Guyer K, Medvecz A, . . . Castellino FJ (2011) Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography. J Extra Corpor Technol 43:162-167.
http://www.ncbi.nlm.nih.gov/pubmed/22164456
Wang R, Zhang SF, Ma YT, Chen D, Ma J, Zhou YM, Wen BZ (2011) [Expression of tissue factor in monocytes and plasma during acute phase and recovery stage of patients with myocardial infarction]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23:372-373.
http://www.ncbi.nlm.nih.gov/pubmed/21672391
Wu Z, Liu MC, Liang M, Fu J (2012) Sirt1 protects against thrombomodulin downregulation and lung coagulation following particulate matter exposure. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22262770
Zhang N, Lawrence DA (2011) Tissue factor and obesity, a two-way street. Nat Med 17:1343-1344.
http://www.ncbi.nlm.nih.gov/pubmed/22064407
Zheng XW, Kudaravalli R, Russell TT, DiMichele DM, Gibb C, Russell JE, . . . Pollak ES (2011) Mutation in the factor VII hepatocyte nuclear factor 4alpha-binding site contributes to factor VII deficiency. Blood Coagul Fibrinolysis 22:624-627.
http://www.ncbi.nlm.nih.gov/pubmed/21760481
Zhou ZY, Hay JW (2012) Efficacy of Bypassing Agents in Patients With Hemophilia and Inhibitors: A Systematic Review and Meta-Analysis. Clin Ther.
http://www.ncbi.nlm.nih.gov/pubmed/22285208
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1XoLfaNpIeJfor-4O9iaF2p/
Abbate R, Cioni G, Ricci I, Miranda M, Gori AM (2012) Thrombosis and Acute coronary syndrome. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22281070
Andersen LM, Andreasen PA, Svendsen I, Keemink J, Ostergaard H, Persson E (2012) Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22275370
Ando K, Ishibashi T, Ohkawara H, Inoue N, Sugimoto K, Uekita H, . . . Takeishi Y (2011) Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP) in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated endothelial cells. J Atheroscler Thromb 18:762-773.
http://www.ncbi.nlm.nih.gov/pubmed/21628952
Angelillo-Scherrer A (2012) Leukocyte-derived microparticles in vascular homeostasis. Circ Res 110:356-369.
http://www.ncbi.nlm.nih.gov/pubmed/22267840
Arderiu G, Pena E, Aledo R, Juan-Babot O, Badimon L (2011) Tissue factor regulates microvessel formation and stabilization by induction of chemokine (C-C motif) ligand 2 expression. Arterioscler Thromb Vasc Biol 31:2607-2615.
http://www.ncbi.nlm.nih.gov/pubmed/21868706
Ataga KI, Brittain JE, Desai P, May R, Jones S, Delaney J, . . . Key NS (2012) Association of coagulation activation with clinical complications in sickle cell disease. PLoS One 7:e29786.
http://www.ncbi.nlm.nih.gov/pubmed/22253781
Badeanlou L, Furlan-Freguia C, Yang G, Ruf W, Samad F (2011) Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat Med 17:1490-1497.
http://www.ncbi.nlm.nih.gov/pubmed/22019885
Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H (2011) Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. J Blood Med 2:131-134.
http://www.ncbi.nlm.nih.gov/pubmed/22287872
Bastarache JA, Sebag SC, Grove BS, Ware LB (2011) Interferon-gamma and tumor necrosis factor-alpha act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res 37:509-517.
http://www.ncbi.nlm.nih.gov/pubmed/21913843
Bobbert P, Eisenreich A, Weithauser A, Schultheiss HP, Rauch U (2011) Leptin and resistin induce increased procoagulability in diabetes mellitus. Cytokine 56:332-337.
http://www.ncbi.nlm.nih.gov/pubmed/21733717
Bretz N, Noske A, Keller S, Erbe-Hofmann N, Schlange T, Salnikov AV, . . . Altevogt P (2012) CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion. Clin Exp Metastasis 29:27-38.
http://www.ncbi.nlm.nih.gov/pubmed/21984372
Brown CV, Sowery L, Curry E, Valadka AB, Glover CS, Grabarkewitz K, . . . Admire J (2012) Recombinant Factor VIIa to Correct Coagulopathy in Patients with Traumatic Brain Injury Presenting to Outlying Facilities Before Transfer to the Regional Trauma Center. Am Surg 78:57-60.
http://www.ncbi.nlm.nih.gov/pubmed/22273315
Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, . . . Valesini G (2012) Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol 167:429-437.
http://www.ncbi.nlm.nih.gov/pubmed/22288586
Donati MB, Lorenzet R (2012) Thrombosis and cancer: 40years of research. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22264938
Ettelaie C, Fountain D, Collier ME, Elkeeb AM, Xiao YP, Maraveyas A (2011) Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-kappaB. Biochim Biophys Acta 1812:1591-1600.
http://www.ncbi.nlm.nih.gov/pubmed/21946214
Fadzil F (2011) Recurrent intracranial haemorrhages in a patient with factor seven deficiency: a case report. Med J Malaysia 66:261-263.
http://www.ncbi.nlm.nih.gov/pubmed/22111455
Foley JH, Butenas S, Mann KG, Brummel-Ziedins KE (2012) Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation. Anal Biochem.
http://www.ncbi.nlm.nih.gov/pubmed/22266209
Forte GI, Vaccarino L, Palmeri M, Branzi A, Caldarera CM, Scola L, . . . Lio D (2011) Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. Biogerontology 12:485-490.
http://www.ncbi.nlm.nih.gov/pubmed/21918818
Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA (2012) Intraoperative use of recombinant activated factor VII during complex aortic surgery. J Thorac Cardiovasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/22285329
Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev 12:CD009052.
http://www.ncbi.nlm.nih.gov/pubmed/22161443
Hall CL, Zaman FS (2012) A Computational Analysis of an In Vitro Vessel Wall Injury Model. Ann Biomed Eng.
http://www.ncbi.nlm.nih.gov/pubmed/22290588
Han CS, Schatz F, Lockwood CJ (2011) Abruption-associated prematurity. Clin Perinatol 38:407-421.
http://www.ncbi.nlm.nih.gov/pubmed/21890016
Hemmeryckx B, Van Hove CE, Fransen P, Emmerechts J, Kauskot A, Bult H, . . . Hoylaerts MF (2011) Progression of the prothrombotic state in aging Bmal1-deficient mice. Arterioscler Thromb Vasc Biol 31:2552-2559.
http://www.ncbi.nlm.nih.gov/pubmed/21799179
Herrera RN, Diaz de Amaya EI, Perez Aguilar RC, Joo Turoni C, Maranon R, Berman SG, . . . Peral de Bruno M (2011) Inflammatory and prothrombotic activation with conserved endothelial function in patients with chronic, asymptomatic Chagas disease. Clin Appl Thromb Hemost 17:502-507.
http://www.ncbi.nlm.nih.gov/pubmed/20699256
Hot A, Lenief V, Miossec P (2012) Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis.
http://www.ncbi.nlm.nih.gov/pubmed/22258491
Jan JY, Lin SY, Lin CH, Lee CN, Fan SZ, Han YY (2011) Recombinant activated factor VII as a promising adjuvant therapy for postpartum hemorrhage in the practice of obstetric anesthesia: experience from a university hospital in Taiwan. J Obstet Gynaecol Res 37:901-907.
http://www.ncbi.nlm.nih.gov/pubmed/21736669
Ji M, Yi S, Yu D, Wang W (2011) [siRNA-mediated tissue factor knockdown in porcine neonatal islet cell clusters in vitro]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36:1141-1146.
http://www.ncbi.nlm.nih.gov/pubmed/22246358
Kassel KM, Owens AP, 3rd, Rockwell CE, Sullivan BP, Wang R, Tawfik O, . . . Luyendyk JP (2011) Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. Am J Pathol 179:2278-2289.
http://www.ncbi.nlm.nih.gov/pubmed/21907177
Kathuria A, Priya N, Chand K, Singh P, Gupta A, Jalal S, . . . Sharma SK (2011) Substrate specificity of acetoxy derivatives of coumarins and quinolones towards Calreticulin mediated transacetylation: Investigations on antiplatelet function. Bioorg Med Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22264757
Kopp CW, Gremmel T, Steiner S, Seidinger D, Minar E, Maurer G, Huber K (2011) Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction. Platelets 22:530-536.
http://www.ncbi.nlm.nih.gov/pubmed/21557685
Kotani Y, Shiota M, Umemoto M, Koike E, Tsuritani M, Hoshiai H (2011) Case of acquired hemophilia with factor VIII inhibitor in a mother and newborn. J Obstet Gynaecol Res 37:1102-1105.
http://www.ncbi.nlm.nih.gov/pubmed/21450023
Le Sache F, Le Bonniec B, Gaussem P, Dizier B, Tagzirt M, Godier A, . . . Samama CM (2012) Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit. Br J Anaesth.
http://www.ncbi.nlm.nih.gov/pubmed/22258204
Leighton BL, Wall MH, Lockhart EM, Phillips LE, Zatta AJ (2011) Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports. Anesthesiology 115:1201-1208.
http://www.ncbi.nlm.nih.gov/pubmed/21720243
Liang YJ, Ma XC, Li X (2010) [The role of p38 mitogen-activated protein kinase/nuclear factor-KappaB transduction pathway on coagulation disorders due to endothelial injury induced by sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22:528-532.
http://www.ncbi.nlm.nih.gov/pubmed/20854731
Lipworth W, Kerridge I, Little M, Day R (2012) Evidence and desperation in off-label prescribing: recombinant factor VIIa. BMJ 344:d7926.
http://www.ncbi.nlm.nih.gov/pubmed/22250217
Liu ML, Williams KJ (2012) Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes.
http://www.ncbi.nlm.nih.gov/pubmed/22248645
Mackman N, Davis GE (2011) Blood coagulation and blood vessel development: is tissue factor the missing link? Arterioscler Thromb Vasc Biol 31:2364-2366.
http://www.ncbi.nlm.nih.gov/pubmed/22011746
Marchetti M, Russo L, Balducci D, Falanga A (2011) All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells. Thromb Res 128:368-374.
http://www.ncbi.nlm.nih.gov/pubmed/21458031
Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol 106:749-760.
http://www.ncbi.nlm.nih.gov/pubmed/21611880
Medioni J, Guastalla JP, Drouet L (2012) Thrombosis and breast cancer: incidence, risk factors, physiopathology and treatment. Bull Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/22285357
Mitrophanov AY, Reifman J (2011) Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 128:381-390.
http://www.ncbi.nlm.nih.gov/pubmed/21641634
Mulder R, Ten Kate MK, Kluin-Nelemans HC, Mulder AB (2012) PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels. Thromb Haemost 107.
http://www.ncbi.nlm.nih.gov/pubmed/22273984
Nadir Y, Kenig Y, Drugan A, Shafat I, Brenner B (2011) An assay to evaluate heparanase procoagulant activity. Thromb Res 128:e3-8.
http://www.ncbi.nlm.nih.gov/pubmed/21481923
Naumnik B, Rydzewska-Rosolowska A, Mysliwiec M (2011) Different effects of enoxaparin, nadroparin, and dalteparin on plasma TFPI during hemodialysis: a prospective crossover randomized study. Clin Appl Thromb Hemost 17:480-486.
http://www.ncbi.nlm.nih.gov/pubmed/20682597
Ogawa Y, Nishida Y, Kyo T, Miki H, Yonemoto H, Bandou H, . . . Shirasaka T (2011) [Successful completion of left total hip arthroplasty by inhibitor neutralization therapy in a hemophilia B patient with high responding inhibitor]. Rinsho Ketsueki 52:713-717.
http://www.ncbi.nlm.nih.gov/pubmed/21897080
Oishi K, Koyanagi S, Ohkura N (2011) Circadian mRNA expression of coagulation and fibrinolytic factors is organ-dependently disrupted in aged mice. Exp Gerontol 46:994-999.
http://www.ncbi.nlm.nih.gov/pubmed/21963655
Pacheco LD, Saade GR, Gei AF, Hankins GD (2011) Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 205:526-532.
http://www.ncbi.nlm.nih.gov/pubmed/21816382
Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, . . . Panteleev MA (2011) Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 9:1825-1834.
http://www.ncbi.nlm.nih.gov/pubmed/21696535
Reimer J, Bien S, Ameling S, Hammer E, Volker U, Hempel G, . . . Ritter CA (2012) Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis. Eur J Clin Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/22286157
Reitter-Pfoertner S, Horvath B, Lechner K, Sunder-Plassmann R, Mannhalter C, Pabinger I (2012) Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challenge. Wien Klin Wochenschr.
http://www.ncbi.nlm.nih.gov/pubmed/22249861
Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, . . . Fremeaux-Bacchi V (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain-of-function. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22246034
Sheth S, Soff G, Mitchell B, Green D, Kaicker S, Fireman F, . . . Aledort L (2012) Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus report. Expert Rev Hematol 5:47-50.
http://www.ncbi.nlm.nih.gov/pubmed/22272705
Stephan F, Aarden LA, Zeerleder S (2012) FSAP, a new player in inflammation? Hamostaseologie 32:51-55.
http://www.ncbi.nlm.nih.gov/pubmed/22252569
Taniguchi M, Ono N, Hayashi A, Yakura Y, Takeya H (2011) Effect of dibutyryl cyclic adenosine monophosphate on the gene expression of plasminogen activator inhibitor-1 and tissue factor in adipocytes. Thromb Res 128:375-380.
http://www.ncbi.nlm.nih.gov/pubmed/21496886
Tetik S, Ak K, Sahin Y, Gulsoy O, Isbir S, Arsan S, Yardimci T (2011) Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. Clin Appl Thromb Hemost 17:526-531.
http://www.ncbi.nlm.nih.gov/pubmed/20805103
Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24-28.
http://www.ncbi.nlm.nih.gov/pubmed/21624643
van der Poll T, Levi M (2012) Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis. Curr Vasc Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/22272914
Walsh M, Thomas SG, Howard JC, Evans E, Guyer K, Medvecz A, . . . Castellino FJ (2011) Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography. J Extra Corpor Technol 43:162-167.
http://www.ncbi.nlm.nih.gov/pubmed/22164456
Wang R, Zhang SF, Ma YT, Chen D, Ma J, Zhou YM, Wen BZ (2011) [Expression of tissue factor in monocytes and plasma during acute phase and recovery stage of patients with myocardial infarction]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23:372-373.
http://www.ncbi.nlm.nih.gov/pubmed/21672391
Wu Z, Liu MC, Liang M, Fu J (2012) Sirt1 protects against thrombomodulin downregulation and lung coagulation following particulate matter exposure. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22262770
Zhang N, Lawrence DA (2011) Tissue factor and obesity, a two-way street. Nat Med 17:1343-1344.
http://www.ncbi.nlm.nih.gov/pubmed/22064407
Zheng XW, Kudaravalli R, Russell TT, DiMichele DM, Gibb C, Russell JE, . . . Pollak ES (2011) Mutation in the factor VII hepatocyte nuclear factor 4alpha-binding site contributes to factor VII deficiency. Blood Coagul Fibrinolysis 22:624-627.
http://www.ncbi.nlm.nih.gov/pubmed/21760481
Zhou ZY, Hay JW (2012) Efficacy of Bypassing Agents in Patients With Hemophilia and Inhibitors: A Systematic Review and Meta-Analysis. Clin Ther.
http://www.ncbi.nlm.nih.gov/pubmed/22285208
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
